|
SKP2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.028190E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.255000E-01 |
| Normal-vs-Stage2 |
4.137000E-01 |
| Normal-vs-Stage3 |
3.964300E-02 |
| Normal-vs-Stage4 |
3.106400E-01 |
| Stage1-vs-Stage2 |
4.360400E-01 |
| Stage1-vs-Stage3 |
3.430300E-02 |
| Stage1-vs-Stage4 |
1.916210E-01 |
| Stage2-vs-Stage3 |
1.702400E-01 |
| Stage2-vs-Stage4 |
4.995000E-01 |
| Stage3-vs-Stage4 |
6.790200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.936600E-01 |
| Normal-vs-AfricanAmerican |
3.157800E-01 |
| Normal-vs-Asian |
3.698600E-01 |
| Caucasian-vs-AfricanAmerican |
7.698000E-01 |
| Caucasian-vs-Asian |
6.857400E-01 |
| AfricanAmerican-vs-Asian |
7.650200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.731600E-01 |
| Normal-vs-Female |
9.807500E-04 |
| Male-vs-Female |
5.161400E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.091200E-01 |
| Normal-vs-Extreme_Weight |
2.372000E-01 |
| Normal-vs-Obese |
1.403000E-01 |
| Normal-vs-Extreme_Obese |
2.562800E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.039960E-01 |
| Normal_Weight-vs-Obese |
9.976200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.375600E-01 |
| Extreme_Weight-vs-Obese |
1.912330E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.003000E-01 |
| Obese-vs-Extreme_Obese |
1.171840E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.037010E-01 |
| Normal-vs-Age(41-60Yrs) |
3.959600E-02 |
| Normal-vs-Age(61-80Yrs) |
9.646800E-01 |
| Normal-vs-Age(81-100Yrs) |
7.322800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.099600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.888200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.234600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.032000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.791400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.027400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.360400E-01 |
| Normal-VS-Type2 PRCC |
2.837000E-01 |
| Normal-VS-KIRP CIMP |
6.838000E-02 |
| Normal-VS-Unclassified PRCC |
1.998250E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.409420E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.351700E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.701200E-03 |
| Type2 PRCC-VS-KIRP CIMP |
1.022810E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.997790E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.867200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.740600E-01 |
| Normal-vs-N1 |
1.392170E-02 |
| Normal-vs-N2 |
8.638400E-01 |
| N0-vs-N1 |
1.847800E-02 |
| N0-vs-N2 |
9.377600E-01 |
| N1-vs-N2 |
3.173600E-01 |
|
|
